Log In
Print this Print this

ATL1103, COR-004

  Manage Alerts
Collapse Summary General Information
Company Antisense Therapeutics Ltd.
DescriptionSecond-generation antisense inhibitor of growth hormone receptor expression
Molecular Target Growth hormone receptor
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationAcromegaly
Indication DetailsTreat acromegaly
Regulatory Designation
Partner Cortendo AB; Isis Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today